Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | -19.55% | 51.29% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -4.45% | 23.76% | |||
Operating Income | 4.45% | -23.76% | |||
Income Before Tax | 10.49% | -18.35% | |||
Income Tax Expenses | -57.14% | 1,168.75% | |||
Earnings from Continuing Operations | 10.61% | -18.64% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 10.61% | -18.64% | |||
EBIT | 4.45% | -23.76% | |||
EBITDA | 4.37% | -24.21% | |||
EPS Basic | 10.99% | -17.61% | |||
Normalized Basic EPS | 10.69% | -22.58% | |||
EPS Diluted | 10.99% | -17.61% | |||
Normalized Diluted EPS | 10.69% | -22.58% | |||
Average Basic Shares Outstanding | 0.42% | 0.88% | |||
Average Diluted Shares Outstanding | 0.42% | 0.88% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |